Editorial: Roles of Hypothesis Testing, p-Values and Decision Making in Biopharmaceutical Research

References

• Bayarri, M., Benjamin, D. J., Berger, J. O., and Sellke, T. M. (2016), “Rejection Odds and Rejection Ratios: A Proposal for Statistical Practice in Testing Hypotheses,” Journal of Mathematical Psychology, 72, 90–103. DOI: 10.1016/j.jmp.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Benjamin, D. J., Berger, J. O., Johannesson, M., Nosek, B. A., Wagenmakers, E., Berk, R., Bollen, K. A., Brembs, B., Brown, L., Camerer, C., Cesarini, D., Chambers, C. D., Clyde, M., Cook, R. D., De Boeck, P., Dienes, Z., Dreber, A., Easwaran, K., Efferson, C., Fehr, E., Fidler, F., Field, A. P., Forster, M., George, E. I., Gonzalez, R., Goodman, S., Green, E., Green, D. P., Greenwald, A. G., Hadfield, J. D., Hedges, L. V., Held, L., Ho, T. H., Hoijtink, H., Hruschka, D. J., Imai, K., Imbens, G., Ioannidis, J. P. A., Jeon, M., Jones, J. H., Kirchler, M., Laibson, D., List, J., Little, R., Lupia, A., Machery, E., Maxwell, S. E., McCarthy, M., Moore, D. A., Morgan, S. L., Munafó, M., Nakagawa, S., Nyhan, B., Parker, T. H., Pericchi, L., Perugini, M., Rouder, J., Rousseau, J., Savalei, V., Schönbrodt, F. D., Sellke, T., Sinclair, B., Tingley, D., Van Zandt, T., Vazire, S., Watts, D. J., Winship, C., Wolpert, R. L., Xie, Y., Young, C., Zinman, J., and Johnson, V. E. (2018), “Redefine Statistical Significance,” Nature Human Behaviour, 2, 6–10. DOI: 10.1038/s41562-017-0189-z.
   PubMed Web of Science ®Google Scholar
• Bornkamp, B., Bretz, F., Dmitrienko, A., Enas, G., Gaydos, B., Hsu, C. H., König, F., Krams, M., Liu, Q., Neuenschwander, B., Parke, T., Pinheiro, J., Roy, A., Sax, R., and Shen, F. (2007), “Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials,” Journal of Biopharmaceutical Statistics, 17, 965–995. DOI: 10.1080/10543400701643848.
   PubMed Web of Science ®Google Scholar
• Chuang-Stein, C., Kirby, S., French, F., Kowalski, K., Marshall, S., Smith, M. K., Bycott, P., and Beltangady, M. (2011), “A Quantitative Approach for Making Go/No-Go Decisions in Drug Development,” Drug Information Journal, 5, 187–202. DOI: 10.1177/009286151104500213.
   Google Scholar
• Cook, J. A., Fergusson, D. A., Ford, I., Gönen, M., Kimmelman, J., Korn, K. L., and Beg, C. B. (2019), “There Is Still a Place for Significance Testing in Clinical Trials,” Clinical Trials, 16, 223–224. DOI: 10.1177/1740774519846504.
   PubMed Web of Science ®Google Scholar
• FDA (2010), “Food and Drug Administration, Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-use-bayesian-statistics-medical-device-clinical-trials-pdf-version.
   Google Scholar
• FDA (2017a), “Food and Drug Administration, Emergency Use Authorization of Medical Products and Related Authorities: Guidance for Industry and Other Stakeholders, January 2017,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities.
   Google Scholar
• FDA (2017b), “Food and Drug Administration, Multiple Endpoints in Clinical Trials Guidance for Industry, January 2017,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/multiple-endpoints-clinical-trials-guidance-industry.
   Google Scholar
• FDA (2019), “Food and Drug Administration, Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products: Guidance for Industry. Draft Guidance December 2019,” available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/demonstrating-substantial-evidence-effectiveness-human-drug-and-biological-products.
   Google Scholar
• Gibson, E. W. (2021), “The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations,” Statistics in Biopharmaceutical Research, 13, DOI: 10.1080/19466315.2020.1724560.(this issue).
   PubMedGoogle Scholar
• Graf, A. C., Posch, M., and König, F. (2015), “Adaptive Designs for Subpopulation Analysis Optimizing Utility Functions,” Biometrical Journal, 57, 76–89. DOI: 10.1002/bimj.201300257.
   PubMed Web of Science ®Google Scholar
• Harrington, D., D’Agostino, R. B., Sr., Gatsonis, C., Hogan, J. W., Hunter, D. J., Normand, S. L. T., Drazen, J. M., and Hamel, M. B. (2019), “New Guidelines for Statistical Reporting in the Journal,” The New England Journal of Medicine, 381, 285–286. DOI: 10.1056/NEJMe1906559.
   PubMed Web of Science ®Google Scholar
• Held, L., and Ott, M. (2018), “On p-Values and Bayes Factors,” Annual Review of Statistics and Its Application, 5, 393–419. DOI: 10.1146/annurev-statistics-031017-100307.
   Web of Science ®Google Scholar
• ICH (1998), “Topic E9 on Statistical Principles for Clinical Trials,” available at www.ich.org.
   Google Scholar
• Ioannidis, J. P. A. (2005), “Why Most Published Research Findings Are False,” PLoS Medicine, 2, e124. DOI: 10.1371/journal.pmed.0020124.
   PubMed Web of Science ®Google Scholar
• Ioannidis, J. P. A. (2008), “Effect of Formal Statistical Significance on the Credibility of Observational Associations,” American Journal of Epidemiology, 168, 374–383.
   PubMed Web of Science ®Google Scholar
• Johnstone, D. J., and Lindley, D. V. (1995), “Bayesian Inference Given Data ‘Significant at α’: Tests of Point Hypotheses,” Theory and Decision, 38, 51–60. DOI: 10.1007/BF01083168.
   Web of Science ®Google Scholar
• Lee, J., Thall, P., and Rezvani, K. (2019), “Optimizing Natural Killer Cell Doses for Heterogeneous Cancer Patients on the Basis of Multiple Event Times,” Journal of the Royal Statistical Society, Series C, 68, 461–474. DOI: 10.1111/rssc.12271.
   Web of Science ®Google Scholar
• Lindley, D. V. (1957), “A Statistical Paradox,” Biometrika, 44, 187– 192. DOI: 10.1093/biomet/44.1-2.187.
   Web of Science ®Google Scholar
• Murray, T., Thall, P., and Yuan, Y. (2016), “Utility-Based Designs for Randomized Comparative Trials With Categorical Outcomes,” Statistics in Medicine, 35, 4285–4305. DOI: 10.1002/sim.6989.
   PubMed Web of Science ®Google Scholar
• Nuzzo, R. (2014), “Scientific Method: Statistical Errors,” Nature, 506, 150–152. DOI: 10.1038/506150a.
   PubMed Web of Science ®Google Scholar
• Sakuma, A. (1999), “Statistics Anecdotes,” in Clinical Trials in the 21st Century, eds. H. Tsubaki, T. Fujita, and T. Sato, Tokyo: Asakura Publishing (in Japanese).
   Google Scholar
• Trafimow, D., and Marks, M. (2015), “Editorial,” Basic and Applied Social Psychology, 37, 1–2, DOI: 10.1080/01973533.2015.1012991.
   Web of Science ®Google Scholar
• U.S. Code of Federal Regulations, available at https://uscode.house.gov/.
   Google Scholar
• Wasserstein, R. L., and Lazar, N. A. (2016), “The ASA Statement on p-Values: Context, Process, and Purpose,” The American Statistician, 70, 129–33. DOI: 10.1080/00031305.2016.1154108.
   Web of Science ®Google Scholar
• Wasserstein, R. L., Schirm, A. L., and Lazar, N. A. (2019), “Moving to a World Beyond ‘p<0.05 ’,” The American Statistician, 73, 1–19.
   Web of Science ®Google Scholar